Skip to main contentBack to Top

The Center's research efforts focus on two main areas:

First, discovery and validation of biomarkers for disease prediction and diagnosis, secondly, pharmacomics and drug discovery for personalized medicine.

Established in the summer of 2002, the Center for Biotechnology and Genomic Medicine (CBGM) at the Medical College of Georgia (MCG) at Augusta University (AU) was developed to promote interdisciplinary and translational research in Biotechnology and Genomic Medicine with the ultimate goal of promoting predictive, preventive, personalized and participatory (4P) medicine.

The Center's research efforts focus on two main areas: 1) discovery and validation of biomarkers for disease prediction and diagnosis, 2) pharmacomics and drug discovery for personalized medicine.  CBGM is home of four internationally renowned programs in diabetes research: The Environmental Determinants of Diabetes in the Young (), the Prospective Assessment in Newborns of Diabetes Autoimmunity (), the Diabetic Complications Consortium () and the Mouse Metabolic Phenotype Consortium (). Additional research programs include autoimmune diseases, transplantation, and cancer. These research programs are supported by an annual extramural funding of approximately $12 million.

The center houses several state-of-the-art high throughput and high content facilities for genetics, genomics, proteomics, drug screening and bioinformatics. The center continues to recruit independent investigators with expertise in diverse disciplines such as genomics, proteomics, immunology, medicinal chemistry, drug development, biostatistics and computational biology. This multidisciplinary approach provides an avenue for investigators to interact and stimulate novel ideas.一元微信提现麻将 

CBGM logo






Contact Us

Center for Biotechnology & Genomic Medicine

一元微信提现麻将Health Sciences Campus

 Sarah Gross
Office Specialist : 706-721-3410
Debbie Ellison
Dept. Admin. : 706-721-3433

 1462 Laney Walker Blvd. Augusta, GA 30912

 8 a.m. - 5 p.m.





Paul Tran is working to develop a highly predictive genetic risk score that will tell parents whether their baby is at significant risk for type 1 diabetes.

一元微信提现麻将MCG investigators working on associating a protein profile in the eye's fluid with obvious structural damage to the eye glaucoma causes. They think that may lead to early detection and new treatment targets for the leading cause of blindness worldwide.

In honor of Black History Month, Augusta University salutes Dr. Bobbilynn Hawkins.

一元微信提现麻将Dr. Jin-Xiong She recently received a fourth renewal on the TEDDY study, which is working to find out how genetics and environmental factors collide and lead to the development of type 1 diabetes in some children.


Nov 01

Speaker: Tae Jin Lee

Nov 08

Speaker: Rebekah Robinson

Nov 15

Speaker: Haitao Liu

Nov 22

Speaker: Xiaoling Wang